{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:15:07Z","timestamp":1753888507150,"version":"3.41.2"},"reference-count":31,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"abstract":"<jats:p>ABSTRACT  Background: Steatotic liver disease (SLD) affects about 1 billion people globally, making its proper management essential to prevent progression to more severe stages.  Objective: The aim of this study was to evaluate medical management concerning hepatic steatosis incidentally identified by ultrasound in patients undergoing elective cholecystectomy.  Methods: This observational, cross-sectional, and retrospective study included patients aged 18 years or older who underwent elective cholecystectomy at Hospital do Trabalhador, in Curitiba\/PR, between 2018 and 2022. Patients with external ultrasound reports or incomplete data in their medical records were excluded. Medical records, laboratory tests, and ultrasound reports were analyzed to evaluate the prevalence of steatosis in these patients.  Results: The study sample consisted of 355 patients, and 103 (29.01%) of them presented steatosis on ultrasound. Older age (P=0.0022), male sex (P=0.03009), higher body mass index (P&lt;0.001), obesity (P&lt;0.001), hypertension (P&lt;0.001), dyslipidemia (P=0.0072), and elevated levels of oxaloacetic and pyruvic aminotransferases (P=0.02112) were associated with the presence of this finding. No action was taken regarding the presence of steatosis in 60.19% of patients. Approximately 39.81% had the finding recorded in their medical records, 6.80% received lifestyle change counseling, and 4.85% were investigated for the stage of steatosis.  Conclusion: A significant prevalence of hepatic steatosis was incidentally identified in the ultrasound of patients undergoing cholecystectomy. However, the approach to this finding was insufficient, highlighting the need for substantial improvements on its management and investigation.<\/jats:p>","DOI":"10.1590\/s0004-2803.24612024-118","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:05:22Z","timestamp":1746183922000},"source":"Crossref","is-referenced-by-count":0,"title":["INCIDENTAL HEPATIC STEATOSIS IDENTIFIED ON ULTRASOUND IN PATIENTS UNDERGOING CHOLECYSTECTOMY: HIGH PREVALENCE AND INSUFFICIENT INVESTIGATIVE AND CLINICAL MANAGEMENT"],"prefix":"10.1590","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4509-2139","authenticated-orcid":false,"given":"Helo\u00edsa Mello","family":"TRAPP","sequence":"first","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brasil; Hospital do Trabalhador,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1577-9195","authenticated-orcid":false,"given":"Paulo Andr\u00e9 Bispo","family":"MACHADO-J\u00daNIOR","sequence":"additional","affiliation":[{"name":"Hospital do Trabalhador,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4232-4279","authenticated-orcid":false,"given":"Silvania Klug","family":"PIMENTEL","sequence":"additional","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brasil; Hospital do Trabalhador,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/imj.14709","article-title":"Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management","volume":"50","author":"Huang T","year":"2020","journal-title":"Intern Med J"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/MOG.0000000000000416","article-title":"Nonalcoholic fatty liver disease, cholesterol gallstones, and cholecystectomy: New insights on a complex relationship","volume":"34","author":"Arrese M","year":"2018","journal-title":"Curr Opin Gastroenterol"},{"key":"ref3","first-page":"19","article-title":"Current management of NAFLD","volume":"89","author":"Munteanu MA","year":"2016","journal-title":"Clujul Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-018-1103-x","article-title":"Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease","volume":"16","author":"Alexander M","year":"2018","journal-title":"BMC Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(24)01811-7","article-title":"Steatotic liver disease","volume":"404","author":"Israelsen M","year":"2024","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease - A global public health perspective","volume":"70","author":"Younossi ZM","year":"2019","journal-title":"J Hepatol"},{"key":"ref7","article-title":"Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies","volume":"22","author":"Chan Kai En","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref8","series-title":"Conectando Pessoas eBooks","volume-title":"Manejo da Doen\u00e7a Hep\u00e1tica Esteat\u00f3tica Metab\u00f3lica (DHEM) no Diabetes Tipo 2 e Pr\u00e9 Diabetes","author":"J\u00fanior S","year":"2024"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1053\/j.sult.2016.08.003","article-title":"Hepatic Steatosis: Etiology, Patterns, and Quantification","volume":"37","author":"Idilman IS","year":"2016","journal-title":"Semin Ultrasound CT MR"},{"key":"ref10","article-title":"A multi-society Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella ME","year":"2024","journal-title":"Hepatology"},{"key":"ref11","first-page":"67","article-title":"Brazilian evidence-based guideline for screening, diagnosis, treatment, and follow-up of metabolic dysfunction-associated steatotic liver disease (MASLD) in adult individuals with overweight or obesity: A joint position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Hepatology (SBH), and Brazilian Association for the Study of Obesity and Metabolic Syndrome (Abeso)","author":"Moreira RO","year":"2023","journal-title":"Arch Endocrinol Metab"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10620-014-3346-5","article-title":"Gaps in Recognition and Evaluation of Incidentally Identified Hepatic Steatosis","volume":"60","author":"Wright AP","year":"2014","journal-title":"Dig Dis Sci"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/1754-9485.12873","article-title":"Incidental hepatic steatosis on unenhanced computed tomography performed for suspected renal colic: Gaps in reporting and documentation","volume":"63","author":"Kutaiba N","year":"2019","journal-title":"J Med Imaging Radiat Oncol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"100359","DOI":"10.1016\/j.aohep.2021.100359","article-title":"NAFLD: Challenges and opportunities to address the public health challenge in Latin America","volume":"24","author":"Arab JP","year":"2021","journal-title":"Ann Hepatol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/gast.2002.35354","article-title":"The utility of radiological imaging in nonalcoholic fatty liver disease","volume":"123","author":"Saadeh S","year":"2002","journal-title":"Gastroenterology"},{"year":"2022","series-title":"R: A language and environment for statistical computing","key":"ref16"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi H","year":"2023","journal-title":"J Hepatol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejim.2023.11.005","article-title":"Natural history of metabolic dysfunction-associated steatotic liver disease","volume":"122","author":"Lekakis V","year":"2024","journal-title":"Eur J Intern Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/apt.17158","article-title":"Review article: the epidemiologic burden of non-alcoholic fatty liver disease across the world","volume":"56","author":"Henry L","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cld.2015.10.001","article-title":"Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World","volume":"20","author":"Sayiner M","year":"2016","journal-title":"Clin Liver Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4291\/wjgp.v12.i2.14","article-title":"Association of non-alcoholic fatty liver disease with gallstone disease in the United States hospitalized patient population","volume":"12","author":"Kichloo A","year":"2021","journal-title":"World J Gastrointest Pathophysiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.21037\/tgh.2019.09.03","article-title":"Cholecystectomy does not worsen progression or outcomes in non-alcoholic fatty liver disease","volume":"5","author":"Kakati D","year":"2020","journal-title":"Transl Gastroenterol Hepatol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.suc.2021.06.004","article-title":"The Bad Gallbladder","volume":"101","author":"Buhavac M","year":"2021","journal-title":"Surg Clin North Am"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell EE","year":"2021","journal-title":"Lancet"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics","volume":"92","author":"Polyzos SA","year":"2019","journal-title":"Metabolism"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/cld.1216","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: A patient-friendly summary of the 2018 AASLD guidelines","volume":"19","author":"Bahirwani R","year":"2022","journal-title":"Clin Liver Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/00325481.2024.2325332","article-title":"Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting","volume":"136","author":"Allen AM","year":"2024","journal-title":"Postgrad Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani N","year":"2018","journal-title":"Hepatology"},{"key":"ref29","first-page":"1212","article-title":"Liver Fat Scores for Noninvasive Diagnosis and Monitoring of Nonalcoholic Fatty Liver Disease in Epidemiological and Clinical Studies","volume":"11","author":"Reinshagen M","year":"2023","journal-title":"J Clin Transl Hepatol"},{"key":"ref30","first-page":"442","article-title":"Re: What Is the Prevalence of Hepatic Steatosis on Ultrasonography in Patients Followed for Nephrolithiasis?","volume":"16","author":"Meria A","year":"2023","journal-title":"Eur Urol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.3748\/wjg.v25.i40.6053","article-title":"Ultrasound-based techniques for the diagnosis of liver steatosis","volume":"25","author":"Ferraioli G","year":"2019","journal-title":"World J Gastroenterol"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":["Esteatose hep\u00e1tica identificada em ultrassonografia em pacientes submetidos \u00e0 colecistectomia: elevada preval\u00eancia e insuficiente investiga\u00e7\u00e3o e conduta cl\u00ednica"],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0004-28032025000100502&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:05:28Z","timestamp":1746183928000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032025000100502&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":31,"alternative-id":["S0004-28032025000100502"],"URL":"https:\/\/doi.org\/10.1590\/s0004-2803.24612024-118","relation":{},"ISSN":["1678-4219","0004-2803"],"issn-type":[{"type":"electronic","value":"1678-4219"},{"type":"print","value":"0004-2803"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"e24118"}}